AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug offers hope for stubborn blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 in people with autoimmune cytopenia, a condition where the immune system attacks blood cells. The drug aims to control the disease by targeting certain immune cells. About 158 adults with relapsed or refractory forms of immune thrombocytop…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 26, 2026 03:29 UTC
-
Engineered immune cells take on autoimmune blood diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, a universal CAR-T cell therapy, in 27 adults with autoimmune blood diseases like immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), or Evans syndrome. The therapy targets specific immune cells to reduce …
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New 'T cell Engager' drug tested for tough autoimmune cases
Disease control Recruiting nowThis early-phase study tests the safety of a new drug called CC312 in up to 18 adults with autoimmune diseases like lupus, arthritis, or scleroderma that haven't responded to standard treatments. CC312 works by directing the body's immune T cells to attack faulty B cells, similar…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: EARLY_PHASE1 • Sponsor: CytoCares Inc • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Blood thinner breakthrough could slash clot risk in rare anemia
Prevention Recruiting nowThis study tests whether taking a blood thinner (apixaban) for 12 weeks can prevent dangerous blood clots in people with autoimmune hemolytic anemia (AIHA), a rare disease where the immune system destroys red blood cells. About 72 adults with newly diagnosed or relapsed AIHA will…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Prevention
Last updated May 22, 2026 14:01 UTC
-
Anemia's hidden toll on the brain revealed by light
Knowledge-focused Recruiting nowThis study uses a non-invasive brain imaging technique called fNIRS to see how anemia affects brain networks involved in thinking and memory. Researchers will monitor brain activity in 323 adults with anemia to identify which brain regions are impacted. The goal is to detect cogn…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 26, 2026 03:24 UTC
-
New french registry aims to uncover real-world patterns in rare blood diseases
Knowledge-focused Recruiting nowThis study is a national registry in France that collects information on adults newly diagnosed with immune thrombocytopenia (ITP) or autoimmune hemolytic anemia (AIHA). Researchers will track up to 1,500 patients to describe how these diseases progress, how they are treated in r…
Matched conditions: AUTOIMMUNE HEMOLYTIC ANEMIA
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC